RMTIROCKWELL MEDICAL, INC.

Nasdaq rockwellmed.com


$ 2.86 $ 0.04 (1.42 %)    

Friday, 30-Aug-2024 15:57:39 EDT
QQQ $ 476.00 $ 0.63 (0.13 %)
DIA $ 416.44 $ 1.60 (0.38 %)
SPY $ 563.62 $ 2.85 (0.51 %)
TLT $ 96.60 $ -1.07 (-1.1 %)
GLD $ 231.30 $ -1.09 (-0.47 %)
$ 2.86
$ 2.82
$ 2.85 x 500
-- x --
$ 2.80 - $ 2.92
$ 1.16 - $ 3.23
366,272
na
90.92M
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 04-08-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-17-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-15-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-15-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-04-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-03-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $9 pri...

 rockwell-medical-projects-net-sales-to-grow-in-the-mid-to-high-single-digits-in-2025-and-beyond-and-gross-margin-in-2025-to-be-approximately-20-and-reaching-above-25-in-2026-and-beyond

GUIDANCERockwell Medical updates its 2024 guidance as follows: Updated 2024 Guidance (As of August 8, 2024)Updated 2024 Guidanc...

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $9 pri...

 rockwell-medical-q1-adj-002-beats-004-estimate-sales-2268m-beat-2170m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0....

 rockwell-medical-enters-new-and-expanded-distribution-agreement-with-bionuclear-and-atlantic-medical-international

In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the Company. The am...

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-9

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

 rockwell-medical-q4-adjusted-eps-002-may-not-be-comparable-to-007-estimate-sales-2210m-miss-2263m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION